195 related articles for article (PubMed ID: 17414231)
1. An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Menza MA; Dobkin RD; Marin H
J Clin Psychopharmacol; 2007 Apr; 27(2):207-10. PubMed ID: 17414231
[No Abstract] [Full Text] [Related]
2. Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine.
Duggal HS; Kithas J
Am J Psychiatry; 2005 Feb; 162(2):397-8. PubMed ID: 15677611
[No Abstract] [Full Text] [Related]
3. Does aripiprazole protect from serotonin syndrome?
Rittmannsberger H; Werl R
Psychiatr Danub; 2012 Mar; 24(1):100-1. PubMed ID: 22447095
[No Abstract] [Full Text] [Related]
4. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.
Labbate LA; Grimes JB; Hines A; Pollack MH
Ann Clin Psychiatry; 1997 Dec; 9(4):241-5. PubMed ID: 9511948
[TBL] [Abstract][Full Text] [Related]
5. Remission of SSRI-induced akathisia after switch to nefazodone.
Chelben J; Strous RD; Lustig M; Baruch Y
J Clin Psychiatry; 2001 Jul; 62(7):570-1. PubMed ID: 11488371
[No Abstract] [Full Text] [Related]
6. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
7. Extrapyramidal side effects associated with aripiprazole coprescription in 2 patients.
Cohen ST; Rulf D; Pies R
J Clin Psychiatry; 2005 Jan; 66(1):135-6. PubMed ID: 15669901
[No Abstract] [Full Text] [Related]
8. Aripiprazole-associated leukopenia with coadministration of fluoxetine: a case report.
Huang LC; Chiang KT
J Clin Psychopharmacol; 2011 Jun; 31(3):376-7. PubMed ID: 21532363
[No Abstract] [Full Text] [Related]
9. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
Papakostas GI; Petersen TJ; Kinrys G; Burns AM; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
J Clin Psychiatry; 2005 Oct; 66(10):1326-30. PubMed ID: 16259548
[TBL] [Abstract][Full Text] [Related]
10. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole augmentation for a patient with partial remission of panic disorder.
Harada T; Yamada K; Sakamoto K; Ishigooka J
J Clin Psychopharmacol; 2009 Jun; 29(3):301-2. PubMed ID: 19440089
[No Abstract] [Full Text] [Related]
12. The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.
Connor KM; Payne VM; Gadde KM; Zhang W; Davidson JR
J Clin Psychiatry; 2005 Jan; 66(1):49-51. PubMed ID: 15669888
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive aripiprazole for bupropion-resistant major depression.
Sokolski KN
Ann Pharmacother; 2008 Jul; 42(7):1124-9. PubMed ID: 18492784
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.
Pessina E; Albert U; Bogetto F; Maina G
Int Clin Psychopharmacol; 2009 Sep; 24(5):265-9. PubMed ID: 19629012
[TBL] [Abstract][Full Text] [Related]
15. An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression.
Rutherford B; Sneed J; Miyazaki M; Eisenstadt R; Devanand D; Sackeim H; Roose S
Int J Geriatr Psychiatry; 2007 Oct; 22(10):986-91. PubMed ID: 17340654
[TBL] [Abstract][Full Text] [Related]
16. Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors.
Adson DE; Kushner MG; Fahnhorst TA
J Affect Disord; 2005 May; 86(1):99-104. PubMed ID: 15820277
[TBL] [Abstract][Full Text] [Related]
17. Low-dose aripiprazole in the treatment of selective serotonin reuptake inhibitors-induced orofacial and buccal dystonia.
Oulis P; Konstantakopoulos G; Nathanailidis E; Tsiamoura M; Kollias K
Psychiatry Clin Neurosci; 2012 Aug; 66(5):462-3. PubMed ID: 22834670
[No Abstract] [Full Text] [Related]
18. A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder.
Matsunaga H; Hayashida K; Maebayashi K; Mito H; Kiriike N
Int J Psychiatry Clin Pract; 2011 Nov; 15(4):263-9. PubMed ID: 22121999
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study.
Quante A; Zeugmann S; Luborzewski A; Schommer N; Langosch J; Born C; Anghelescu I; Wolf J
Hum Psychopharmacol; 2010 Mar; 25(2):126-32. PubMed ID: 20196183
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response.
Richtand NM; Ahlbrand R; Horn P; Tambyraja R; Grainger M; Bronson SL; McNamara RK
Physiol Behav; 2012 May; 106(2):171-7. PubMed ID: 22342193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
